Her2-Receptor Negative Breast Cancer

Her2-Receptor Negative Breast Cancer is related to her2-receptor positive breast cancer and cervical adenocarcinoma. An important gene associated with Her2-Receptor Negative Breast Cancer is ACSL4 (Acyl-CoA Synthetase Long Chain Family Member 4), and among its related pathways/superpathways are Signaling by Receptor Tyrosine Kinases and Breast cancer pathway. The drugs Lenograstim and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include breast and liver, and related phenotypes are Decreased viability in pancreas lineage and normal